# NORETHINDRONE
> **ANDA202014** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2013-09-13
## Drug
- **FDA Application Number:** ANDA202014
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NORETHINDRONE
- **Generic name:** NORETHINDRONE
- **Active ingredients:** NORETHINDRONE
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Prescription
- **Sponsor:** NOVAST LABS
- **Manufacturer:** Northstar Rx LLC
- **First approval:** 2013-09-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202014)
---
*AI Analytics · CC0 1.0*